DexCom Shares Outstanding 2010-2024 | DXCM

DexCom shares outstanding for the quarter ending June 30, 2024 were 0.417B, a 3.41% decline year-over-year.

  • DexCom 2023 shares outstanding were 0.426B, a 0.47% decline from 2022.
  • DexCom 2022 shares outstanding were 0.428B, a 0.3% decline from 2021.
  • DexCom 2021 shares outstanding were 0.429B, a 2% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

DexCom Shares Outstanding 2010-2024 | DXCM

  • DexCom 2023 shares outstanding were 0.426B, a 0.47% decline from 2022.
  • DexCom 2022 shares outstanding were 0.428B, a 0.3% decline from 2021.
  • DexCom 2021 shares outstanding were 0.429B, a 2% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$233.2B
Intuitive Surgical (ISRG)$171.7B
Alcon (ALC)$47.9B
IQVIA Holdings (IQV)$43.7B
IDEXX Laboratories (IDXX)$42.2B
Edwards Lifesciences (EW)$40.5B
STERIS (STE)$23.8B
SONOVA HOLDING (SONVY)$21.2B
Waters (WAT)$19.5B
Hologic (HOLX)$19B
Sysmex ADR (SSMXY)$12.6B
Fresenius Medical Care AG KGaA (FMS)$12.3B
Teleflex (TFX)$11.4B
Globus Medical (GMED)$9.4B
Penumbra (PEN)$7.3B
Glaukos (GKOS)$6.7B
Masimo (MASI)$6.1B
TransMedics (TMDX)$5.2B
Integer Holdings (ITGR)$4.2B
PROCEPT BioRobotics (PRCT)$4.1B
Tandem Diabetes Care (TNDM)$2.8B
LivaNova (LIVN)$2.8B
Veracyte (VCYT)$2.6B
Inari Medical (NARI)$2.6B
Elekta AB (EKTAY)$2.5B
Nihon Kohden (NHNKY)$2.5B
RxSight (RXST)$2.1B
Integra LifeSciences Holdings (IART)$1.3B
Pulse Biosciences (PLSE)$1.2B
OPKO Health (OPK)$1.2B